Neuronetics presents financial and operational outlook at William Blair conference

Neuronetics, Inc.

Presentation provides FY2024 outlook metrics but specific numbers not extracted.
Outlook includes revenue, expenses, growth expectations; risks detailed in SEC filings.
Company expects cash flow break-even in Q4 2024 and full-year 2025 goal mentioned.
No update on prior guidance; presentation is furnished, not filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.